首页 > 最新文献

Brain Hemorrhages最新文献

英文 中文
Computational fluid dynamics using dual-layer porous media modeling to evaluate the hemodynamics of cerebral aneurysm treated with FRED: A technical note 利用双层多孔介质模拟计算流体动力学来评价FRED治疗脑动脉瘤的血流动力学:技术说明
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.hest.2022.05.007
Masanori Tsuji , Fujimaro Ishida , Takenori Sato , Kazuhiro Furukawa , Yoichi Miura , Ryuta Yasuda , Yasuyuki Umeda , Naoki Toma , Hidenori Suzuki

Flow diverter (FD) implantation is increasingly performed for aneurysms that are difficult to treat with conventional endovascular therapy and direct surgery. Now, a new FD stent, the Flow-Redirection Endoluminal Device (FRED), enters into clinical practice and is expected to have higher therapeutic efficacy. To predict whether an aneurysm is completely occluded by FRED, we have developed a novel computational fluid dynamics (CFD) technique using dual-layer porous media modeling that simulates its characteristic stent strut. This technique may be useful to evaluate hemodynamic changes in an aneurysm after FRED implantation using the preoperative patient-specific aneurysm geometry. The authors describe the novel CFD technique with a dual-layer porous media and report the potential usefulness of the technique to predict the aneurysm-occlusion status after FRED implantation preoperatively using an illustrative case of an unruptured internal carotid artery anterior wall aneurysm.

分流器(FD)植入术越来越多地用于传统血管内治疗和直接手术难以治疗的动脉瘤。现在,一种新的FD支架,流动重定向腔内装置(FRED),进入临床实践,有望具有更高的治疗效果。为了预测动脉瘤是否被FRED完全闭塞,我们开发了一种新的计算流体动力学(CFD)技术,该技术使用双层多孔介质建模来模拟其特征支架支柱。该技术可能有助于使用术前患者特异性动脉瘤几何形状来评估FRED植入后动脉瘤的血液动力学变化。作者描述了具有双层多孔介质的新型CFD技术,并以未破裂的颈内动脉前壁动脉瘤为例,报告了该技术在术前预测FRED植入后动脉瘤闭塞状态方面的潜在实用性。
{"title":"Computational fluid dynamics using dual-layer porous media modeling to evaluate the hemodynamics of cerebral aneurysm treated with FRED: A technical note","authors":"Masanori Tsuji ,&nbsp;Fujimaro Ishida ,&nbsp;Takenori Sato ,&nbsp;Kazuhiro Furukawa ,&nbsp;Yoichi Miura ,&nbsp;Ryuta Yasuda ,&nbsp;Yasuyuki Umeda ,&nbsp;Naoki Toma ,&nbsp;Hidenori Suzuki","doi":"10.1016/j.hest.2022.05.007","DOIUrl":"https://doi.org/10.1016/j.hest.2022.05.007","url":null,"abstract":"<div><p>Flow diverter (FD) implantation is increasingly performed for aneurysms that are difficult to treat with conventional endovascular therapy and direct surgery. Now, a new FD stent, the Flow-Redirection Endoluminal Device (FRED), enters into clinical practice and is expected to have higher therapeutic efficacy. To predict whether an aneurysm is completely occluded by FRED, we have developed a novel computational fluid dynamics (CFD) technique using dual-layer porous media modeling that simulates its characteristic stent strut. This technique may be useful to evaluate hemodynamic changes in an aneurysm after FRED implantation using the preoperative patient-specific aneurysm geometry. The authors describe the novel CFD technique with a dual-layer porous media and report the potential usefulness of the technique to predict the aneurysm-occlusion status after FRED implantation preoperatively using an illustrative case of an unruptured internal carotid artery anterior wall aneurysm.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49744415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Pediatric hemorrhagic stroke: A retrospective case series in Hong Kong 儿童出血性中风:香港的回顾性病例系列
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.hest.2022.05.006
Jacqueline Fung Chak Lam, Eric Yuk Hong Cheung, Emily Kit Ying Chan, Xian Lun Zhu, Rebecca Yuen Ting Ng, George Kwok Chu Wong

Background

Non-traumatic paediatric haemorrhagic stroke (PHS) is a common cause of death in children. We aimed to delineate the aetiologies of PHS and compare the outcomes of various management approaches to improve the treatment for children with PHS.

Methods

A retrospective analysis of PHS patients from a tertiary neurosurgical centre was conducted. Outcomes were evaluated based on the 30-day complication rate, rebleeding rate and functional outcome using the Modified Rankin Scale.

Results

39 patients were identified. The most common presentation for older children was severe headache, whereas symptoms were non-specific in younger children. Structural vascular lesions are the most common cause of PHS and 46% had arteriovenous malformation. 56% of patients received acute surgical intervention. 47% of patients were treated conservatively in the acute setting requiring interval definitive surgeries. Surgically managed patients experienced a higher 30-day complication rate but lower rebleeding rate. Functional outcome is good for PHS and most patients had full recovery.

Conclusions

Ruptured cerebral arteriovenous malformation was the most common cause of PHS and sudden onset of severe headache was the key presenting symptom. Prompt surgical intervention for PHS reduced the rebleeding rate.

背景儿童非创伤性出血性脑卒中(PHS)是儿童常见的死亡原因。我们旨在描述PHS的病因,并比较各种管理方法的结果,以改善儿童PHS的治疗。方法对某三级神经外科中心PHS患者进行回顾性分析。使用改良Rankin量表,根据30天并发症发生率、再出血率和功能结果评估结果。结果共鉴定39例。年龄较大的儿童最常见的表现是严重头痛,而年龄较小的儿童症状不明确。结构性血管病变是PHS最常见的病因,46%的患者有动静脉畸形。56%的患者接受了急性手术干预。47%的患者在需要间隔明确手术的急性情况下接受了保守治疗。外科治疗的患者30天并发症发生率较高,但再出血率较低。PHS的功能结果良好,大多数患者已完全康复。结论脑动静脉畸形破裂是PHS最常见的病因,突发剧烈头痛是其主要表现症状。PHS的及时手术干预降低了再出血率。
{"title":"Pediatric hemorrhagic stroke: A retrospective case series in Hong Kong","authors":"Jacqueline Fung Chak Lam,&nbsp;Eric Yuk Hong Cheung,&nbsp;Emily Kit Ying Chan,&nbsp;Xian Lun Zhu,&nbsp;Rebecca Yuen Ting Ng,&nbsp;George Kwok Chu Wong","doi":"10.1016/j.hest.2022.05.006","DOIUrl":"https://doi.org/10.1016/j.hest.2022.05.006","url":null,"abstract":"<div><h3>Background</h3><p>Non-traumatic paediatric haemorrhagic stroke (PHS) is a common cause of death in children. We aimed to delineate the aetiologies of PHS and compare the outcomes of various management approaches to improve the treatment for children with PHS.</p></div><div><h3>Methods</h3><p>A retrospective analysis of PHS patients from a tertiary neurosurgical centre was conducted. Outcomes were evaluated based on the 30-day complication rate, rebleeding rate and functional outcome using the Modified Rankin Scale.</p></div><div><h3>Results</h3><p>39 patients were identified. The most common presentation for older children was severe headache, whereas symptoms were non-specific in younger children. Structural vascular lesions are the most common cause of PHS and 46% had arteriovenous malformation. 56% of patients received acute surgical intervention. 47% of patients were treated conservatively in the acute setting requiring interval definitive surgeries. Surgically managed patients experienced a higher 30-day complication rate but lower rebleeding rate. Functional outcome is good for PHS and most patients had full recovery.</p></div><div><h3>Conclusions</h3><p>Ruptured cerebral arteriovenous malformation was the most common cause of PHS and sudden onset of severe headache was the key presenting symptom. Prompt surgical intervention for PHS reduced the rebleeding rate.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49744844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging regenerative medicine for hemorrhagic stroke: An update on stem cell therapies 出血性中风的新兴再生医学:干细胞疗法的最新进展
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.hest.2022.07.001
Molly Monsour , Cesario V. Borlongan

Hemorrhagic stroke (HS) is a disastrous occurrence with high mortality rates, however, there are no established treatments for this pathology. Given recent advances in stem cell therapies, concerted research efforts have elucidated the therapeutic potential of stem cells in treating HS. In 2020, our group reviewed the use of SCs in regulating the neuroinflammatory reactions which occur after HS.1 This review will build on that work, highlighting more recent advancements in the field of SC treatments for HS. Ultimately, with greater focus in this area of research, innovative SC therapies can be optimized in preclinical studies and soon be transferred to clinical applications for HS therapeutics.

出血性中风(HS)是一种灾难性的疾病,死亡率很高,但目前还没有确定的治疗方法。鉴于干细胞疗法的最新进展,一致的研究工作已经阐明了干细胞在治疗HS方面的治疗潜力。2020年,我们的小组回顾了SC在调节HS后发生的神经炎症反应中的应用。1这篇综述将以这项工作为基础,强调SC治疗HS领域的最新进展。最终,随着对这一研究领域的更多关注,创新的SC疗法可以在临床前研究中进行优化,并很快转移到HS疗法的临床应用中。
{"title":"Emerging regenerative medicine for hemorrhagic stroke: An update on stem cell therapies","authors":"Molly Monsour ,&nbsp;Cesario V. Borlongan","doi":"10.1016/j.hest.2022.07.001","DOIUrl":"https://doi.org/10.1016/j.hest.2022.07.001","url":null,"abstract":"<div><p>Hemorrhagic stroke (HS) is a disastrous occurrence with high mortality rates, however, there are no established treatments for this pathology. Given recent advances in stem cell therapies, concerted research efforts have elucidated the therapeutic potential of stem cells in treating HS. In 2020, our group reviewed the use of SCs in regulating the neuroinflammatory reactions which occur after HS.<sup>1</sup> This review will build on that work, highlighting more recent advancements in the field of SC treatments for HS. Ultimately, with greater focus in this area of research, innovative SC therapies can be optimized in preclinical studies and soon be transferred to clinical applications for HS therapeutics.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49744526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Delayed cerebral ischemia associated with surgery for pituitary macroadenomas that express elevated levels of PACAP 迟发性脑缺血与垂体大腺瘤PACAP表达水平升高的手术相关
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.hest.2022.05.003
Dominic A. Siler , Kate U. Rosen , Stephen G. Bowden , Andrew Y. Powers , Jesse J. Liu , Aclan Dogan , Holly E. Hinson , Maria Fleseriu , Randy L. Woltjer , Justin S. Cetas

Delayed cerebral ischemia (DCI) and cerebral vasospasm (VS) are rare but serious post-operative complications after surgery for pituitary macroadenomas; the mechanism of which are poorly understood. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a vasoactive neuropeptide expressed in pituitary adenomas and may play a role in DCI/VS. The aim of this case-control study was to investigate the association between tumor expression of PACAP and DCI/VS following pituitary surgery. Tumor tissue from five patients with DCI/VS following pituitary surgery and nine matched controls were evaluated for PACAP expression by immunohistochemistry. Nuclear PACAP expression was significantly elevated in patients with DCI/VS following pituitary surgery compared to controls (0.396 ± 0.0.16 a.u. vs 0.093 ± 0.04 a.u, p < 0.0001). There was a positive linear relationship between nuclear PACAP expression and pre-operative tumor volume (r2 = 0.41, p < 0.02) with a significant difference in slopes between the DCI/VS group compared to controls (y = x(5.0 × 10−3), r2 = 0.76 vs y = x(7.4 × 10−4), r2 = 0.07, p < 0.05). Elevated levels of tumor PACAP expression is associated with DCI/VS following pituitary surgery and may have a role in tumor growth. PACAP signaling may play a role the development of DCI, but further studies are needed.

延迟性脑缺血(DCI)和脑血管痉挛(VS)是垂体大腺瘤术后罕见但严重的并发症;其机理尚不清楚。垂体腺苷酸环化酶激活多肽(PACAP)是一种在垂体腺瘤中表达的血管活性神经肽,可能在DCI/VS中发挥作用。本病例对照研究的目的是研究垂体手术后PACAP的肿瘤表达与DCI/VS之间的关系。通过免疫组织化学方法评估5例垂体手术后DCI/VS患者和9例匹配对照的肿瘤组织中PACAP的表达。与对照组相比,垂体手术后DCI/VS患者的细胞核PACAP表达显著升高(0.396±0.0.16 a.u.VS 0.093±0.04 a.u.,p<;0.0001)。细胞核PACAP的表达与术前肿瘤体积呈正线性关系(r2=0.41,p&llt;0.02),DCI/VS组与对照组之间的斜率存在显著差异对照组(y=x(5.0×10−3),r2=0.76 vs y=x(7.4×10−4),r2=0.07,p<;肿瘤PACAP表达水平的升高与垂体手术后的DCI/VS相关,并且可能在肿瘤生长中起作用。PACAP信号可能在DCI的发展中发挥作用,但还需要进一步的研究。
{"title":"Delayed cerebral ischemia associated with surgery for pituitary macroadenomas that express elevated levels of PACAP","authors":"Dominic A. Siler ,&nbsp;Kate U. Rosen ,&nbsp;Stephen G. Bowden ,&nbsp;Andrew Y. Powers ,&nbsp;Jesse J. Liu ,&nbsp;Aclan Dogan ,&nbsp;Holly E. Hinson ,&nbsp;Maria Fleseriu ,&nbsp;Randy L. Woltjer ,&nbsp;Justin S. Cetas","doi":"10.1016/j.hest.2022.05.003","DOIUrl":"https://doi.org/10.1016/j.hest.2022.05.003","url":null,"abstract":"<div><p>Delayed cerebral ischemia (DCI) and cerebral vasospasm (VS) are rare but serious post-operative complications after surgery for pituitary macroadenomas; the mechanism of which are poorly understood. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a vasoactive neuropeptide expressed in pituitary adenomas and may play a role in DCI/VS. The aim of this case-control study was to investigate the association between tumor expression of PACAP and DCI/VS following pituitary surgery. Tumor tissue from five patients with DCI/VS following pituitary surgery and nine matched controls were evaluated for PACAP expression by immunohistochemistry. Nuclear PACAP expression was significantly elevated in patients with DCI/VS following pituitary surgery compared to controls (0.396 ± 0.0.16 a.u. vs 0.093 ± 0.04 a.u, p &lt; 0.0001). There was a positive linear relationship between nuclear PACAP expression and pre-operative tumor volume (r<sup>2</sup> = 0.41, p &lt; 0.02) with a significant difference in slopes between the DCI/VS group compared to controls (y = x(5.0 × 10<sup>−3</sup>), r<sup>2</sup> = 0.76 vs y = x(7.4 × 10<sup>−4</sup>), r<sup>2</sup> = 0.07, p &lt; 0.05). Elevated levels of tumor PACAP expression is associated with DCI/VS following pituitary surgery and may have a role in tumor growth. PACAP signaling may play a role the development of DCI, but further studies are needed.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49744602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pituitary apoplexy following adenoviral vector-based COVID-19 vaccination 基于腺病毒载体的COVID-19疫苗接种后垂体性中风
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.hest.2022.04.002
Luca Roncati, Antonio Manenti

Pituitary apoplexy (PA) may complicate the course of coronavirus disease 2019 (COVID-19), posing a potential threat to life. Among vaccines designed to prevent COVID-19, there are those adenoviral vector-based, such as Vaxzevria® (formerly COVID-19 Vaccine AstraZeneca). The product insert states that it can cause very rare coagulation disorders, in particular thrombosis with thrombocytopenia syndrome in some cases accompanied by bleeding, cerebrovascular venous or sinus thrombosis, and thrombocytopenia, including immune thrombocytopenia, also associated with bleeding. Here, we report the onset of PA after Vaxzevria® in a 28-year-old healthy Caucasian female, who experienced long-lasting tension-type headache, hyperprolactinemia and menstrual changes, without thrombocytopenia or thrombosis.

垂体卒中(PA)可能使2019冠状病毒病(新冠肺炎)的过程复杂化,对生命构成潜在威胁。在旨在预防新冠肺炎的疫苗中,有一些是基于腺病毒载体的疫苗,如Vaxzevria®(前身为新冠肺炎疫苗阿斯利康)。该产品说明书指出,它会导致非常罕见的凝血障碍,特别是血栓形成伴血小板减少综合征,在某些情况下伴有出血,脑血管静脉或鼻窦血栓形成,以及血小板减少症,包括免疫性血小板减少症也与出血有关。在此,我们报告了一名28岁的健康高加索女性在服用Vaxzevria®后出现PA,她经历了长期的紧张型头痛、高泌乳素血症和月经变化,没有血小板减少或血栓形成。
{"title":"Pituitary apoplexy following adenoviral vector-based COVID-19 vaccination","authors":"Luca Roncati,&nbsp;Antonio Manenti","doi":"10.1016/j.hest.2022.04.002","DOIUrl":"https://doi.org/10.1016/j.hest.2022.04.002","url":null,"abstract":"<div><p>Pituitary apoplexy (PA) may complicate the course of coronavirus disease 2019 (COVID-19), posing a potential threat to life. Among vaccines designed to prevent COVID-19, there are those adenoviral vector-based, such as Vaxzevria® (formerly COVID-19 Vaccine AstraZeneca). The product insert states that it can cause very rare coagulation disorders, in particular thrombosis with thrombocytopenia syndrome in some cases accompanied by bleeding, cerebrovascular venous or sinus thrombosis, and thrombocytopenia, including immune thrombocytopenia, also associated with bleeding. Here, we report the onset of PA after Vaxzevria® in a 28-year-old healthy Caucasian female, who experienced long-lasting tension-type headache, hyperprolactinemia and menstrual changes, without thrombocytopenia or thrombosis.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49757866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Middle meningeal embolization for chronic subdural Hematoma: A case series of 7 patients and review of time course of resolution 中脑膜栓塞治疗慢性硬膜下血肿:7例病例及治疗时间回顾
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.hest.2022.04.004
G.K. Wong , E.Y. Cheung , R.Y. Ng , S.C. Yu , D.Y. Chan , J.T. Zhuang

Introduction

Chronic subdural hematoma (CSDH) is common in elderly after a mild or trivial head injury. The concern for embolization is the period to wait, as compared to immediate relief of mass effect from surgery. Thus, a combination approach is advocated in our center when in doubt. We here reported our initial experience and observation with respect to time course of resolution.

Method

We retrospectively reviewed all the patients with CSDH undergoing Onyx middle meningeal artery (MMA) embolization with curative intent and excluded patients for palliative treatment in a neurosurgical center in Hong Kong.

Results

Four (50%) CSDH were treated with MMA embolization alone and 4(50%) CSDH were treated with both surgery and MMA embolization. For the 4 patients with MMA embolization alone, one(25%) achieved significant reduction at 6 weeks and 3(75%) achieved resolution at 3 months. For the 4 CSDH with both surgery and MMA embolization, all have resolution at the first follow-up imaging, two(50%) at 6 weeks and 2(50%) at 3 months. There were no procedure related complications, and there were no recurrence nor reoperation in all CSDH.

Conclusion

MMA embolization is safe and feasible within the framework of surgery to cure and prevent recurrence.

慢性硬膜下血肿(CSDH)常见于轻度或轻微头部损伤后的老年人。与手术后立即缓解肿块影响相比,栓塞需要等待一段时间。因此,当我们有疑问时,我们中心提倡采用组合方法。我们在这里报告了我们在解决时间进程方面的初步经验和观察。方法回顾性分析了所有在香港神经外科中心接受Onyx脑膜中动脉(MMA)栓塞治疗的CSDH患者,并排除了姑息治疗的患者。对于4名单独使用MMA栓塞的患者,1名(25%)在6周时显著减少,3名(75%)在3个月时消退。对于同时进行手术和MMA栓塞的4例CSDH,所有患者在第一次随访成像时都有分辨率,6周时有2例(50%),3个月时有2名(50%)。所有CSDH均无手术相关并发症,无复发或再次手术。结论MMA栓塞在手术治疗和预防复发的框架内是安全可行的。
{"title":"Middle meningeal embolization for chronic subdural Hematoma: A case series of 7 patients and review of time course of resolution","authors":"G.K. Wong ,&nbsp;E.Y. Cheung ,&nbsp;R.Y. Ng ,&nbsp;S.C. Yu ,&nbsp;D.Y. Chan ,&nbsp;J.T. Zhuang","doi":"10.1016/j.hest.2022.04.004","DOIUrl":"https://doi.org/10.1016/j.hest.2022.04.004","url":null,"abstract":"<div><h3>Introduction</h3><p>Chronic subdural hematoma (CSDH) is common in elderly after a mild or trivial head injury. The concern for embolization is the period to wait, as compared to immediate relief of mass effect from surgery. Thus, a combination approach is advocated in our center when in doubt. We here reported our initial experience and observation with respect to time course of resolution.</p></div><div><h3>Method</h3><p>We retrospectively reviewed all the patients with CSDH undergoing Onyx middle meningeal artery (MMA) embolization with curative intent and excluded patients for palliative treatment in a neurosurgical center in Hong Kong.</p></div><div><h3>Results</h3><p>Four (50%) CSDH were treated with MMA embolization alone and 4(50%) CSDH were treated with both surgery and MMA embolization. For the 4 patients with MMA embolization alone, one(25%) achieved significant reduction at 6 weeks and 3(75%) achieved resolution at 3 months. For the 4 CSDH with both surgery and MMA embolization, all have resolution at the first follow-up imaging, two(50%) at 6 weeks and 2(50%) at 3 months. There were no procedure related complications, and there were no recurrence nor reoperation in all CSDH.</p></div><div><h3>Conclusion</h3><p>MMA embolization is safe and feasible within the framework of surgery to cure and prevent recurrence.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49744802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Analysis of clinical misdiagnosis literature on cerebral venous sinus thrombosis 脑静脉窦血栓形成临床误诊文献分析
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.hest.2022.07.005
Yucai Guo , Desislava Doycheva

Intracranial venous sinus thrombosis (cerebral venous sinus thrombosis, CVST) clinical manifestations and signs are often atypical, and the form of the disease is variable. With the improvement of diagnostic technology and clinical understanding, the detection rate of this disease is on the rise, but the misdiagnosis rate is still at a high level. The goal of our review article is to shed light on CVST to help reduce clinician’s misdiagnosis of the disease.

Methods

A total of 18 misdiagnosed CVST documents were published in Chinese medical journals from 2016 to 2020.

Results

The scope of misdiagnosis involves 22 diseases. The top three misdiagnosed diseases are cerebral hemorrhage, cerebral infarction, and encephalitis. The main reasons for misdiagnosis are the lack of understanding of the disease, the lack of understanding of the imaging manifestations of CVST, the lack of specific symptoms and signs, and the wrong diagnostic thinking methods to meet the diagnosis of common diseases. A total of 51 misdiagnosed cases described the relationship between misdiagnosis and disease outcome, of which 46 cases (90.20%) did not cause adverse consequences due to misdiagnosis.

Conclusion

It is crucial for clinicians to improve their understanding of CVST, and patients that present with headache, increased intracranial pressure, and focal neurological deficits could potentially have CVST and should be promptly sent to get cranial magnetic resonance imaging and magnetic resonance venography or digital subtraction angiography. The differential diagnosis should be checked and strengthened in order to reduce the occurrence of misdiagnosis.

颅内静脉窦血栓形成(脑静脉窦血栓,CVST)的临床表现和体征往往不典型,且疾病形式多变。随着诊断技术和临床认识的提高,该病的检出率呈上升趋势,但误诊率仍处于较高水平。我们的综述文章的目的是阐明CVST,以帮助减少临床医生对该疾病的误诊。方法从2016年到2020年,共有18篇被误诊的CVST文献发表在中国医学杂志上。结果误诊范围涉及22种疾病。误诊最多的三种疾病是脑出血、脑梗死和脑炎。误诊的主要原因是对疾病缺乏了解,对CVST的影像学表现缺乏了解,缺乏具体的症状和体征,以及满足常见疾病诊断的错误诊断思维方法。共有51例误诊病例描述了误诊与疾病结果的关系,其中46例(90.20%)没有因误诊而造成不良后果。结论临床医生提高对CVST的认识至关重要,头痛、颅内压升高和局灶性神经功能缺损的患者可能患有CVST,应立即送去进行颅骨磁共振成像、磁共振静脉造影或数字减影血管造影术。应检查和加强鉴别诊断,以减少误诊的发生。
{"title":"Analysis of clinical misdiagnosis literature on cerebral venous sinus thrombosis","authors":"Yucai Guo ,&nbsp;Desislava Doycheva","doi":"10.1016/j.hest.2022.07.005","DOIUrl":"https://doi.org/10.1016/j.hest.2022.07.005","url":null,"abstract":"<div><p>Intracranial venous sinus thrombosis (cerebral venous sinus thrombosis, CVST) clinical manifestations and signs are often atypical, and the form of the disease is variable. With the improvement of diagnostic technology and clinical understanding, the detection rate of this disease is on the rise, but the misdiagnosis rate is still at a high level. The goal of our review article is to shed light on CVST to help reduce clinician’s misdiagnosis of the disease.</p></div><div><h3>Methods</h3><p>A total of 18 misdiagnosed CVST documents were published in Chinese medical journals from 2016 to 2020.</p></div><div><h3>Results</h3><p>The scope of misdiagnosis involves 22 diseases. The top three misdiagnosed diseases are cerebral hemorrhage, cerebral infarction, and encephalitis. The main reasons for misdiagnosis are the lack of understanding of the disease, the lack of understanding of the imaging manifestations of CVST, the lack of specific symptoms and signs, and the wrong diagnostic thinking methods to meet the diagnosis of common diseases. A total of 51 misdiagnosed cases described the relationship between misdiagnosis and disease outcome, of which 46 cases (90.20%) did not cause adverse consequences due to misdiagnosis.</p></div><div><h3>Conclusion</h3><p>It is crucial for clinicians to improve their understanding of CVST, and patients that present with headache, increased intracranial pressure, and focal neurological deficits could potentially have CVST and should be promptly sent to get cranial magnetic resonance imaging and magnetic resonance venography or digital subtraction angiography. The differential diagnosis should be checked and strengthened in order to reduce the occurrence of misdiagnosis.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49744524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glymphatic system and post-hemorrhagic hydrocephalus 淋巴系统和出血性脑积水
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.hest.2022.06.001
Fenghui Ye, Richard F. Keep, Ya Hua, Hugh J.L. Garton, Guohua Xi

The glymphatic system is a recently identified route for exchanging parenchyma interstitial fluid and cerebrospinal fluid along perivascular space, facilitating brain waste clearance. Glymphatic system dysfunction has been reported in many neurological diseases. Here we discussed the possible role of glymphatic system in posthemorrhagic brain injury, especially posthemorrhagic hydrocephalus.

淋巴系统是最近确定的一种沿着血管周围空间交换实质间质液和脑脊液的途径,有助于清除脑废物。据报道,许多神经系统疾病都存在淋巴系统功能障碍。在此,我们讨论了glymphatic系统在缺血性脑损伤,特别是缺血性脑积水中的可能作用。
{"title":"Glymphatic system and post-hemorrhagic hydrocephalus","authors":"Fenghui Ye,&nbsp;Richard F. Keep,&nbsp;Ya Hua,&nbsp;Hugh J.L. Garton,&nbsp;Guohua Xi","doi":"10.1016/j.hest.2022.06.001","DOIUrl":"10.1016/j.hest.2022.06.001","url":null,"abstract":"<div><p>The glymphatic system is a recently identified route for exchanging parenchyma interstitial fluid and cerebrospinal fluid along perivascular space, facilitating brain waste clearance. Glymphatic system dysfunction has been reported in many neurological diseases. Here we discussed the possible role of glymphatic system in posthemorrhagic brain injury, especially posthemorrhagic hydrocephalus.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260252/pdf/nihms-1855659.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9623580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Possible synergism of tissue plasminogen activator and neurocysticercosis leading to intracranial hemorrhage 组织纤溶酶原激活剂与脑囊虫病导致颅内出血的可能协同作用
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.hest.2022.04.001
Ravi Rajmohan , Dai Nguyen , Noel Miner , Steven Park , Hermelinda Abcede , Mohammad Shafie

Neurocysticercosis (NCC) remains the most common helminth infection of the human central nervous system worldwide. Patients with NCC are especially predisposed to cerebrovascular events such as acute ischemic stroke (AIS), intracerebral hemorrhage (ICH), and subarachnoid hemorrhage due to an immune-mediated process in which infiltration of inflammatory cells into blood vessel walls leads to endothelial hyperplasia and endarteritis, known as cysticercotic angiitis. Additionally, the oncosphere of the parasite causing NCC produces T. solium enolase, an enzyme which binds and activates human plasminogen receptor proteins to plasmin, leading to a hypercoagulable state. Currently, NCC is not a contraindication to administration of tissue plasminogen activator (tPA) for a suspected AIS. However, to our knowledge, it has not been assessed whether the presence of NCC increases the likelihood of hemorrhagic conversion of an AIS after tPA administration. We present the case of an 83-year-old lady with NCC who developed multifocal right-sided ICH involving the temporal, parietal, and frontal lobes six and a half hours after tPA administration for a suspected AIS. Given this event and the cellular mechanisms provided, we recommend a safety surveillance study to further determine the potential risks of hemorrhagic conversion in this population.

脑囊虫病(NCC)仍然是世界范围内人类中枢神经系统最常见的蠕虫感染。NCC患者特别容易发生脑血管事件,如急性缺血性中风(AIS)、脑出血(ICH)和蛛网膜下腔出血,这是由于免疫介导的过程,在这个过程中,炎症细胞浸润到血管壁导致内皮增生和动脉内膜炎,即囊尾蚴血管炎。此外,引起NCC的寄生虫的肿瘤细胞产生T.solium烯醇化酶,这是一种将人类纤溶酶原受体蛋白与纤溶酶结合并激活的酶,导致高凝状态。目前,对于疑似AIS,NCC不是组织纤溶酶原激活剂(tPA)给药的禁忌症。然而,据我们所知,尚未评估NCC的存在是否会增加tPA给药后AIS出血性转化的可能性。我们报告了一例83岁的NCC患者,她在服用tPA治疗疑似AIS 6个半小时后,出现了涉及颞叶、顶叶和额叶的多灶性右侧脑出血。鉴于这一事件和所提供的细胞机制,我们建议进行一项安全性监测研究,以进一步确定该人群中出血性转化的潜在风险。
{"title":"Possible synergism of tissue plasminogen activator and neurocysticercosis leading to intracranial hemorrhage","authors":"Ravi Rajmohan ,&nbsp;Dai Nguyen ,&nbsp;Noel Miner ,&nbsp;Steven Park ,&nbsp;Hermelinda Abcede ,&nbsp;Mohammad Shafie","doi":"10.1016/j.hest.2022.04.001","DOIUrl":"https://doi.org/10.1016/j.hest.2022.04.001","url":null,"abstract":"<div><p>Neurocysticercosis (NCC) remains the most common helminth infection of the human central nervous system worldwide. Patients with NCC are especially predisposed to cerebrovascular events such as acute ischemic stroke (AIS), intracerebral hemorrhage (ICH), and subarachnoid hemorrhage due to an immune-mediated process in which infiltration of inflammatory cells into blood vessel walls leads to endothelial hyperplasia and endarteritis, known as cysticercotic angiitis. Additionally, the oncosphere of the parasite causing NCC produces <em>T. solium</em> enolase, an enzyme which binds and activates human plasminogen receptor proteins to plasmin, leading to a hypercoagulable state. Currently, NCC is not a contraindication to administration of tissue plasminogen activator (tPA) for a suspected AIS. However, to our knowledge, it has not been assessed whether the presence of NCC increases the likelihood of hemorrhagic conversion of an AIS after tPA administration. We present the case of an 83-year-old lady with NCC who developed multifocal right-sided ICH involving the temporal, parietal, and frontal lobes six and a half hours after tPA administration for a suspected AIS. Given this event and the cellular mechanisms provided, we recommend a safety surveillance study to further determine the potential risks of hemorrhagic conversion in this population.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49744743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reliability of Siriraj stroke score to distinguish between hemorrhagic and ischemic stroke Siriraj卒中评分区分出血性卒中和缺血性卒中的可靠性
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.hest.2022.07.002
Iqra Athar, Adil Muhammad Malik, Neelma Naz Khattak, Anam Anis, Mansoor Iqbal, Haris Majid, Mazhar Badshah

Objective

The aim of study was to establish a quick way to differentiate between hemorrhagic and ischemic stroke by using siriraj stroke score and find its specificity and sensitivity by comparing it with CT scan findings.

Study design

Cross-sectional study.

Place and duration of study

Department of Neurology Pakistan Institute of Medical Sciences Islamabad from Jan 2021 to June 2021.

Methodology

Total 110 patients of acute stroke were included. Any patient of > 20 years old, non-traumatic, focal neurological deficit < 14 days with no obvious reason other than vascular were included. Siriraj stroke score was calculated its findings were compared with a CT scan findings. Data was analyzed by SPSS ver.23.0.

Results

The mean age of patients was 66.10 ± 14.58 years. There were 54 (49.10 %) males and 56 (50.90 %) females. Hypertension was the most common disease found in 79 (71.8 %). The sensitivity, specificity, PPV and NPV of Siriraj stroke score was 83.87 %, 66.6 %, 74.2 % and 71.42 % respectively for hemorrhagic stroke and 93.4 %, 80.95 %, 93.4 % and 37.03 % respectively for non-hemorrhagic stroke.

Conclusion

It is an easy, cost effective and bed side scoring system which can accurately identify the stroke type without any other radiological investigation. It can be employed in areas where CT scan facility is not available and treatment can be started early which will definitely lower mortality and morbidity of stroke patients.

目的建立一种利用siriraj脑卒中评分快速区分出血性脑卒中和缺血性脑卒中的方法,并通过与CT扫描结果的比较来寻找其特异性和敏感性。研究设计横断面研究。研究地点和持续时间巴基斯坦医学科学研究所神经内科伊斯兰堡,2021年1月至2021年6月。方法共纳入110名急性脑卒中患者。任何>;20岁,非创伤性,局灶性神经功能缺损<;14天,除血管外无明显原因。计算Siriraj中风评分,将其结果与CT扫描结果进行比较。结果患者平均年龄为66.10±14.58岁,男性54例(49.10%),女性56例(50.90%)。高血压是79例患者中最常见的疾病(71.8%)。Siriraj卒中评分的敏感性、特异性、PPV和NPV对出血性卒中分别为83.87%、66.6%、74.2%和71.42%,对非出血性卒中则分别为93.4%、80.95%、93.4%和37.03%。结论这是一种简单、经济有效的床侧评分系统,无需任何其他放射学检查即可准确识别中风类型。它可以用于没有CT扫描设施的地区,并且可以尽早开始治疗,这肯定会降低中风患者的死亡率和发病率。
{"title":"Reliability of Siriraj stroke score to distinguish between hemorrhagic and ischemic stroke","authors":"Iqra Athar,&nbsp;Adil Muhammad Malik,&nbsp;Neelma Naz Khattak,&nbsp;Anam Anis,&nbsp;Mansoor Iqbal,&nbsp;Haris Majid,&nbsp;Mazhar Badshah","doi":"10.1016/j.hest.2022.07.002","DOIUrl":"https://doi.org/10.1016/j.hest.2022.07.002","url":null,"abstract":"<div><h3>Objective</h3><p>The aim of study was to establish a quick way to differentiate between hemorrhagic and ischemic stroke by using siriraj stroke score and find its specificity and sensitivity by comparing it with CT scan findings.</p></div><div><h3>Study design</h3><p>Cross-sectional study.</p></div><div><h3>Place and duration of study</h3><p>Department of Neurology Pakistan Institute of Medical Sciences Islamabad from Jan 2021 to June 2021.</p></div><div><h3>Methodology</h3><p>Total 110 patients of acute stroke were included. Any patient of &gt; 20 years old, non-traumatic, focal neurological deficit &lt; 14 days with no obvious reason other than vascular were included. Siriraj stroke score was calculated its findings were compared with a CT scan findings. Data was analyzed by SPSS ver.23.0.</p></div><div><h3>Results</h3><p>The mean age of patients was 66.10 ± 14.58 years. There were 54 (49.10 %) males and 56 (50.90 %) females. Hypertension was the most common disease found in 79 (71.8 %). The sensitivity, specificity, PPV and NPV of Siriraj stroke score was 83.87 %, 66.6 %, 74.2 % and 71.42 % respectively for hemorrhagic stroke and 93.4 %, 80.95 %, 93.4 % and 37.03 % respectively for non-hemorrhagic stroke.</p></div><div><h3>Conclusion</h3><p>It is an easy, cost effective and bed side scoring system which can accurately identify the stroke type without any other radiological investigation. It can be employed in areas where CT scan facility is not available and treatment can be started early which will definitely lower mortality and morbidity of stroke patients.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49744848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Brain Hemorrhages
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1